Vacuum foam drying for preservation of LaSota virus: Effect of additives

AAPS PharmSciTech

Volumn 7, Issue 3, 2006, Pages

  Pisal, Sambhaji ^a   Wawde, Gopal ^a   Salvankar, Shailendra ^a   Lade, Sanjay ^a   Kadam, Shivajirao ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

Additives; Foam drying; LaSota virus; Stabilization

Indexed keywords

AMINE; AMINO ACID; DISACCHARIDE; DRUG ADDITIVE; FRUCTOSE; GALACTOSE; MACROGOL 6000; MONOSACCHARIDE; NEWCASTLE DISEASE VACCINE; POLOXAMER; POLYMER; POVIDONE; SUCROSE; TREHALOSE;

AQUEOUS SOLUTION; ARTICLE; CATALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DESICCATION; DILUTION; DISPERSION; DRUG FORMULATION; DRUG HYDROLYSIS; DRUG POTENCY; DRUG STABILITY; FOAM; FREEZE DRYING; MOISTURE; NONHUMAN; VACUUM; VIRUS TITRATION; X RAY DIFFRACTION;

EID: 33746601754     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt070360     Document Type: Article

References (23)

1. Skrabanja AT, de Meere AL, de Ruiter RA, van den Oetelaar PJ. Lyophilization of biotechnology products. PDA J Pharm Sci Technol. 1994;48:311-317.
2. Mumenthaler M, Hsu CC, Pearlman R. Feasibility study on spray dried protein pharmaceuticals: recombinant human growth hormone and tissue type plasminogen activator. Pharm Res. 1994; 11:12-20.
3. Koseki T, Kitabatake N, Doi E. Freezing denaturation of ovalbumin at acid pH. J Biochem (Tokyo). 1990;107:389-394.
4. Pearlman R, Nguyen T. Pharmaceutics of protein drugs. J Pharm Pharmacol. 1992;44:178-185.
5. Kerwin BA, Heller MC, Levin SH, Randolph TW. Effects of tween 80 and sucrose on acute short-term stability and long-term storage at -20°C of recombinant hemoglobin. J Pharm Sci. 1998;87:1062-1068.
6. Mi Y, Wood G, Thoma L, Rashed S. Effects of polyethylene glycol molecular weight and concentration on lactate dehydrogenase activity after freeze-thawing. PDA J Pharm Sci Technol. 2002;56: 115-123.
7. Andersson MM, Hatti-Kaul R. Protein stabilizing effect of polyethyleneimine. J Biotechnol. 1999;72:21-31.
8. Ressing ME, Jiskoot W, Talsma H, Van ICW, Beuvery EC, Crommelin DJ. The influence of sucrose, dextran, and hydroxypropyl-beta-cyclodextrin as lyoprotectants for a freeze-dried mouse IgG2a monoclonal antibody (MN12). Pharm Res. 1992;9:266-270.
9. Nakai Y, Yoshioka S, Aso Y, Kojima S. Solid-state rehydration-induced recovery of bilirubin oxidase activity in lyophilized formulations reduced during freeze-drying. Chem Pharm Bull (Tokyo). 1998;46: 1031-1033.
10. Bronshtein V, inventor. Scalable long-term shelf preservation of sensitive biological solutions and suspensions. US patent 6 509 146. February 17, 2004.
11. Pisal SS, Shah MH, Mahadik KR, Paradkar AR. Process development and lyophilization cycle optimization for lasota vaccine (A57). Fifty Third Indian Pharmaceutical Congress; December 23, 2001; New Delhi, India.
12. Kadam SS, Mane JJ, Shah MH, Pisal SS. Effect of excipients on product characteristics and structure of lyophilized lasota vaccine. Indian J Biotechnol. 2005;4:106-114.
13. Pisal SS, Wawde GM, More HN, Kadam SS. Vacuum foam drying for preservation of lasota virus: screening of foaming agent and cycle optimization. Indian J Biotechnol. In press.
14. Allan WH, Lancaster JE. Newcastle Disease Vaccines. Rome, Italy: Food and Agricultural Organization of the United Nations; 1978:52-54.
15. Wawade GM. Vacuum Foam Drying for Stabilization of Sensitive Biologicals (Lasota Vaccine) [master's thesis]. Pune, India: Bharati Vidyapeeth Deemed University; 2004.
16. Anchordoquy TJ, Carpenter JF. Polymers protect lactate dehydrogenase during freeze-drying by inhibiting dissociation in the frozen state. Arch Biochem Biophys. 1996;332:231-238.
17. House JA, Mariner JC. Stabilization of rinderpest vaccine by modification of the lyophilization process. Dev Biol Stand. 1996; 87:235-244.
18. Levine H, Slade L. Another view of trehalose for drying and stabilizing biological materials. Biopharm. 1992;5:36-40.
19. Nema S, Avis KE. Freeze-thaw studies of model protein, lactate dehydrogenase, in the presence of cryoprotectants. J Parenter Sei Technol. 1993;47:76-83.
20. Tanaka K, Takeda T. Cryoprotective effect of saccharides on denaturation of catalase by freeze-drying. Chem Pharm Bull (Tokyo). 1991;39:1091-1094.
21. Arakawa T, Prestrelski SJ, Kenney W, Carpenter JF. Factors affecting short-term and long-term stabilities of proteins. Adv Drug Deliv Rev. 2001;46:307-326.
22. Kim AI, Akers MJ, Nail SL. The physical state of mannitol after freeze-drying: effects of mannitol concentration, freezing rate and a noncrystallizing cosolute. J Pharm Sci. 1998;87:931-935.
23. Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203:1-60.